Blaise Clarke

13.7k total citations
162 papers, 5.1k citations indexed

About

Blaise Clarke is a scholar working on Reproductive Medicine, Molecular Biology and Obstetrics and Gynecology. According to data from OpenAlex, Blaise Clarke has authored 162 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Reproductive Medicine, 45 papers in Molecular Biology and 43 papers in Obstetrics and Gynecology. Recurrent topics in Blaise Clarke's work include Ovarian cancer diagnosis and treatment (59 papers), Endometrial and Cervical Cancer Treatments (40 papers) and Genetic factors in colorectal cancer (23 papers). Blaise Clarke is often cited by papers focused on Ovarian cancer diagnosis and treatment (59 papers), Endometrial and Cervical Cancer Treatments (40 papers) and Genetic factors in colorectal cancer (23 papers). Blaise Clarke collaborates with scholars based in Canada, United States and United Kingdom. Blaise Clarke's co-authors include C. Blake Gilks, Steve E. Kalloger, Marcus Q. Bernardini, W. Glenn McCluggage, C. Blake Gilks, Amit M. Oza, William D. Foulkes, Martin Köbel, Patricia Shaw and Runjan Chetty and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Blaise Clarke

155 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Blaise Clarke Canada	44	1.9k	1.6k	1.5k	1.4k	1.0k	162	5.1k
Maria Luisa Carcangiu Italy	42	1.9k 1.0×	1.8k 1.1×	2.0k 1.3×	1.4k 1.0×	1.0k 1.0×	101	7.4k
Charles Zaloudek United States	41	2.0k 1.1×	1.2k 0.8×	616 0.4×	1.4k 1.1×	459 0.5×	83	5.4k
Bjørn Risberg Norway	41	788 0.4×	1.8k 1.1×	1.4k 0.9×	534 0.4×	877 0.9×	131	4.6k
K. Czerwenka Austria	41	781 0.4×	1.5k 0.9×	1.3k 0.8×	1.0k 0.7×	646 0.6×	179	4.6k
Olga B. Ioffe United States	32	663 0.4×	796 0.5×	898 0.6×	917 0.7×	1.0k 1.0×	112	4.3k
G. Gitsch Austria	35	762 0.4×	1.1k 0.7×	1.0k 0.7×	834 0.6×	811 0.8×	166	3.7k
Simon A. Gayther United Kingdom	47	1.8k 1.0×	3.7k 2.2×	1.5k 1.0×	365 0.3×	1.6k 1.6×	136	7.0k
Klaske A. ten Hoor Netherlands	30	757 0.4×	734 0.4×	1.1k 0.7×	789 0.6×	416 0.4×	53	2.7k
Rajmohan Murali United States	51	568 0.3×	3.1k 1.9×	4.3k 2.9×	745 0.5×	1.6k 1.6×	179	8.5k
Kosuke Yoshihara Japan	31	1.1k 0.6×	4.6k 2.8×	3.1k 2.0×	722 0.5×	3.3k 3.3×	103	9.1k

Countries citing papers authored by Blaise Clarke

Since Specialization

Citations

This map shows the geographic impact of Blaise Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blaise Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blaise Clarke more than expected).

Fields of papers citing papers by Blaise Clarke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blaise Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blaise Clarke. The network helps show where Blaise Clarke may publish in the future.

Co-authorship network of co-authors of Blaise Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Blaise Clarke. A scholar is included among the top collaborators of Blaise Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blaise Clarke. Blaise Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brill, Julia, Blaise Clarke, Ingie Hong, & Richard L. Huganir. (2025). Dissociation of SYNGAP1 enzymatic and structural roles: Intrinsic excitability and seizure susceptibility. Proceedings of the National Academy of Sciences. 122(18). e2427288122–e2427288122. 5 indexed citations

Zyla, Roman, et al.. (2025). 1121 Ovarian Tumours Harbouring PTCH1::GLI1 Fusions Demonstrate Histologic Features Which Overlap With More Well-Defined Sex Cord-Stromal Tumors, and are Associated with a Progressive, Relapsing Clinical Course. Laboratory Investigation. 105(3). 103355–103355.

Ahmed, Iman, et al.. (2025). Selecting high-throughput scanners for clinical use: A multicenter institution experience. American Journal of Clinical Pathology. 164(4). 589–599. 1 indexed citations

Daniel, M., Rajkumar Vajpeyi, Blaise Clarke, et al.. (2025). From Microscopes to Monitors: Unique Opportunities and Challenges in Digital Pathology Implementation in Remote Canadian Regions. Diagnostics. 15(16). 1983–1983.

Ahmed, Iman, et al.. (2025). An adapted & improved validation protocol for digital pathology implementation. Seminars in Diagnostic Pathology. 42(4). 150905–150905. 3 indexed citations

Zyla, Roman, David W. Dodington, Sara Pakbaz, et al.. (2024). Assessment of Interobserver Agreement Among Gynecologic Pathologists Between Three-Tier Versus Binary Pattern-based Classification Systems for HPV-associated Endocervical Adenocarcinoma. The American Journal of Surgical Pathology. 48(12). 1522–1529.

Khan, Md Shahjalal Hossain, Sun Ok Fernandez‐Kim, Blaise Clarke, et al.. (2024). FGF21 acts in the brain to drive macronutrient-specific changes in behavioral motivation and brain reward signaling. Molecular Metabolism. 91. 102068–102068. 5 indexed citations

Chung, Douglas C., Maryam Ghaedi, Kathrin Warner, et al.. (2024). Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors. OncoImmunology. 13(1). 2349347–2349347. 1 indexed citations

Bruce, Christine, et al.. (2024). Transforming diagnostics: The implementation of digital pathology in clinical laboratories. Histopathology. 85(2). 207–214. 11 indexed citations

10.

Hussain, Ali, Véronique Voisin, Stephanie Poon, et al.. (2020). Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21. The Journal of Experimental Medicine. 217(8). 64 indexed citations

11.

Brett, Mary Anne, Eshetu G. Atenafu, Nilanchali Singh, et al.. (2020). Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous Carcinoma. International Journal of Gynecological Pathology. 40(2). 116–123. 51 indexed citations

12.

Yoon, Ju‐Yoon, María Apellániz-Ruiz, Stuart Salfinger, et al.. (2020). The Value of DICER1 Mutation Analysis in “Subtle” Diagnostically Challenging Embryonal Rhabdomyosarcomas of the Uterine Cervix. International Journal of Gynecological Pathology. 40(5). 435–440. 7 indexed citations

13.

Allo, Ghassan, Mei Ling Yap, Julie Cuartero, et al.. (2019). HPV-independent Vulvar Squamous Cell Carcinoma is Associated With Significantly Worse Prognosis Compared With HPV-associated Tumors. International Journal of Gynecological Pathology. 39(4). 391–399. 45 indexed citations

14.

Plotkin, Anna, Boris Kuzeljevic, Emily F. Thompson, et al.. (2019). Interlaboratory Concordance of ProMisE Molecular Classification of Endometrial Carcinoma Based on Endometrial Biopsy Specimens. International Journal of Gynecological Pathology. 39(6). 537–545. 35 indexed citations

15.

Toker, Aras, Linh T. Nguyen, Simone C. Stone, et al.. (2018). Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma. Clinical Cancer Research. 24(22). 5685–5696. 85 indexed citations

16.

Kroeger, David R., Katy Milne, Aline Talhouk, et al.. (2016). Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy. Clinical Cancer Research. 23(4). 925–934. 128 indexed citations

17.

Díaz-Padilla, Iván, Michelle Wilson, Blaise Clarke, et al.. (2015). A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia. Gynecologic Oncology. 137(2). 216–222. 62 indexed citations

18.

El‐Bahrawy, Mona, Steve E. Kalloger, Najla Aldaoud, et al.. (2014). Current Morphologic Criteria Perform Poorly in Identifying Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome-associated Uterine Leiomyomas. International Journal of Gynecological Pathology. 33(6). 560–567. 17 indexed citations

19.

Mujčić, Hilda, Anika Nagelkerke, Kasper M.A. Rouschop, et al.. (2013). Hypoxic Activation of the PERK/eIF2α Arm of the Unfolded Protein Response Promotes Metastasis through Induction of LAMP3. Clinical Cancer Research. 19(22). 6126–6137. 106 indexed citations

20.

Chaudary, Naz, Melania Pintilie, David W. Hedley, et al.. (2011). Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation. Cancer. 118(12). 3105–3115. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact